Skip to content

A clinical decision tool for rapid assessment of cardiac chest pain.

Rapid assessment of cardiac chest pain: A prospective validation trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000206921
Enrollment
1051
Registered
2011-02-22
Start date
2011-02-16
Completion date
2014-03-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this study is to prospectively investigate the accuracy and safety of an accelerated chest pain diagnostic pathway in patients presenting with intermediate risk chest pain in an Australian setting. The primary objective is to demonstrate the sensitivity, specificity and predictive values of the rule for ACS-related diagnoses at 30 days post discharge. The secondary objective is to demonstrate the sensitivity, specificity and predictive values of the rule for the composite oucome of patients who are admitted to hospital for potential ACS. That is, those with an ACS related diagnosis or significant exercise stress test (EST) findings (positive or indeterminate results).

Interventions

Patients presenting to the Emergency Department will be assessed using a newly developed risk stratification process for acute coronary syndrome. Patients will be deemed HIGH risk according to the high risk criteria of the National Heart Foundation/CS-ANZ guidelines 2006. Patients will be deemed VERY LOW risk if: Age <40, no history of DM, no renal impairment, normal (<= 0.04mcg/L) initial troponin and normal ECG. All others are INTERMEDIATE risk. This risk stratification will be applied in the

Patients presenting to the Emergency Department will be assessed using a newly developed risk stratification process for acute coronary syndrome. Patients will be deemed HIGH risk according to the high risk criteria of the National Heart Foundation/CS-ANZ guidelines 2006. Patients will be deemed VERY LOW risk if: Age <40, no history of DM, no renal impairment, normal (<= 0.04mcg/L) initial troponin and normal ECG. All others are INTERMEDIATE risk. This risk stratification will be applied in the Emergency Department on presentation, with ECG and troponin results available. This intervention is administered for the period of the index presentation.

Sponsors

Investigator initiated study - Dr Louise Cullen, Senior Staff Specialist
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient with symptoms of greater than or equal to 5 minutes consistent with possible ACS (chest discomfort or angina equivalent) AND/OR Physician plans to evaluate the patient for potential ACS AND Intermediate risk features on QLD CPP

Exclusion criteria

More than 2 hours since arrival at hopsital. Patient (or Legal Representative) is unable or unwilling to provide informed consent. Transfer from other hosptial. Patient (or Legal Representative) refusal of telephone follow-up or medical record review at 30 days or unlikely to be contactable for follow-up. Reasearcher does not feel that informed consent is obtainable or that recruitment is apporpriate (e.g. terminal illness). Pregnant. Clear alternative non-ACS diagnostic cause for symptoms. High risk features according to QLD CPP.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 26, 2026